Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs
Francesca Solagna, … , Ketan Patel, Tobias B. Huber
Francesca Solagna, … , Ketan Patel, Tobias B. Huber
Published June 1, 2021
Citation Information: J Clin Invest. 2021;131(11):e135821. https://doi.org/10.1172/JCI135821.
View: Text | PDF
Research Article Muscle biology Nephrology Article has an altmetric score of 47

Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs

  • Text
  • PDF
Abstract

Skeletal muscle wasting is commonly associated with chronic kidney disease (CKD), resulting in increased morbidity and mortality. However, the link between kidney and muscle function remains poorly understood. Here, we took a complementary interorgan approach to investigate skeletal muscle wasting in CKD. We identified increased production and elevated blood levels of soluble pro-cachectic factors, including activin A, directly linking experimental and human CKD to skeletal muscle wasting programs. Single-cell sequencing data identified the expression of activin A in specific kidney cell populations of fibroblasts and cells of the juxtaglomerular apparatus. We propose that persistent and increased kidney production of pro-cachectic factors, combined with a lack of kidney clearance, facilitates a vicious kidney/muscle signaling cycle, leading to exacerbated blood accumulation and, thereby, skeletal muscle wasting. Systemic pharmacological blockade of activin A using soluble activin receptor type IIB ligand trap as well as muscle-specific adeno-associated virus–mediated downregulation of its receptor ACVR2A/B prevented muscle wasting in different mouse models of experimental CKD, suggesting that activin A is a key factor in CKD-induced cachexia. In summary, we uncovered a crosstalk between kidney and muscle and propose modulation of activin signaling as a potential therapeutic strategy for skeletal muscle wasting in CKD.

Authors

Francesca Solagna, Caterina Tezze, Maja T. Lindenmeyer, Shun Lu, Guochao Wu, Shuya Liu, Yu Zhao, Robert Mitchell, Charlotte Meyer, Saleh Omairi, Temel Kilic, Andrea Paolini, Olli Ritvos, Arja Pasternack, Antonios Matsakas, Dominik Kylies, Julian Schulze zur Wiesch, Jan-Eric Turner, Nicola Wanner, Viji Nair, Felix Eichinger, Rajasree Menon, Ina V. Martin, Barbara M. Klinkhammer, Elion Hoxha, Clemens D. Cohen, Pierre-Louis Tharaux, Peter Boor, Tammo Ostendorf, Matthias Kretzler, Marco Sandri, Oliver Kretz, Victor G. Puelles, Ketan Patel, Tobias B. Huber

×

Total citations by year

Year: 2025 2024 2023 2022 2021 Total
Citations: 4 5 12 6 1 28
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (28)

Title and authors Publication Year
Multiomics Analysis Reveals Therapeutic Targets for Chronic Kidney Disease With Sarcopenia
Wang M, You L, He X, Peng Y, Wang R, Zhang Z, Shu J, Zhang P, Sun X, Jia L, Xia Z, Ji C, Gao C
Journal of Cachexia, Sarcopenia and Muscle 2025
Sarcopenia in Chronic Kidney Disease: A Narrative Review from Pathophysiology to Therapeutic Approaches
Tsai CC, Wang PC, Hsiung T, Fan YH, Wu JT, Kan WC, Shiao CC
Biomedicines 2025
Combating chronic kidney disease-associated cachexia: A literature review of recent therapeutic approaches
Rahbar Saadat Y, Abbasi A, Hejazian SS, Hekmatshoar Y, Ardalan M, Farnood F, Zununi Vahed S
BMC Nephrology 2025
Molecular and Cellular Mechanisms Linking Chronic Kidney Disease and Sarcopenia in Aging: An Integrated Perspective
Chang J, Liang Y, Sun P, Fang X, Sun Q
Clinical Interventions in Aging 2025
Common mouse models of chronic kidney disease are not associated with cachexia
Benjamin Lair, Marlène Lac, Lucas Frassin, Manon Brunet, Marie Buleon, Guylène Feuillet, Claire Maslo, Marie Marquès, Laurent Monbrun, Geneviève Tavernier, Emilie Montastier, Nathalie Viguerie, Virginie Bourlier, Claire Laurens, Cedric Moro
Communications biology 2024
The Rise of Hypothesis-Driven Artificial Intelligence in Oncology.
Xianyu Z, Correia C, Ung CY, Zhu S, Billadeau DD, Li H
Cancers 2024
Skeletal Muscle Injury in Chronic Kidney Disease—From Histologic Changes to Molecular Mechanisms and to Novel Therapies
Heitman K, Alexander MS, Faul C
International journal of molecular sciences 2024
In chronic kidney disease altered cardiac metabolism precedes cardiac hypertrophy
Williams MJ, Halabi CM, Patel HM, Joseph Z, McCommis K, Weinheimer C, Kovacs A, Lima F, Finck B, Malluche H, Hruska KA
American Journal of Physiology - Renal Physiology 2024
Improved health by combining dietary restriction and promoting muscle growth in DNA repair‐deficient progeroid mice
Vermeij WP, Alyodawi K, van Galen I, von der Heide JL, Birkisdóttir MB, van't Sant LJ, Ozinga RA, Komninos DS, Smit K, Rijksen YM, Brandt RM, Barnhoorn S, Jaarsma D, Vaiyapuri S, Ritvos O, Huber TB, Kretz O, Patel K
Journal of Cachexia, Sarcopenia and Muscle 2024
MG53: A potential therapeutic target for kidney disease.
Ke B, Shen W, Song J, Fang X
Pharmacology Research & Perspectives 2023
Skeletal muscle single fiber force production declines early in juvenile male mice with chronic kidney disease.
Momb BA, Patino E, Akchurin OM, Miller MS
Physiological Reports 2023
Urotensin II can Induce Skeletal Muscle Atrophy Associated with Upregulating Ubiquitin-Proteasome System and Inhibiting the Differentiation of Satellite Cells in CRF Mice.
Pan Y, Zhou T, Dong X, Wu L, Wang P, Wang S, Zhang A
Calcified Tissue International 2023
Redox Signaling in Chronic Kidney Disease-Associated Cachexia
Simões e Silva AC, Oliveira EA, Cheung WW, Mak RH
Antioxidants 2023
Insights into human kidney function from the study of Drosophila.
Koehler S, Huber TB
Pediatric nephrology (Berlin, Germany) 2023
Anabolic Resistance in the Pathogenesis of Sarcopenia in the Elderly: Role of Nutrition and Exercise in Young and Old People
Tezze C, Sandri M, Tessari P
Nutrients 2023
Trunk muscle quality and quantity are associated with renal volume in nondiabetic people
Tanaka M, Okada H, Hashimoto Y, Kumagai M, Yamaoka M, Nishimura H, Fukui M
Clinical Kidney Journal 2023
Plasma activin A rises with declining kidney function and is independently associated with mortality in patients with chronic kidney disease
Nordholm A, Sørensen IM, Bjergfelt SS, Fuchs A, Kofoed KF, Landler NE, Biering-Sørensen T, Carlson N, Feldt-Rasmussen B, Christoffersen C, Bro S
Clinical Kidney Journal 2023
Mammalian target of rapamycin inhibition impacts energy homeostasis and induces sex‐specific body weight loss in humans
Mannaa M, Pfennigwerth P, Fielitz J, Gollasch M, Boschmann M
Journal of Cachexia, Sarcopenia and Muscle 2023
Skeletal muscle atrophy in clinical and preclinical models of chronic kidney disease: A systematic review and meta‐analysis
Troutman AD, Arroyo E, Sheridan EM, D'Amico DJ, Brandt PR, Hinrichs R, Chen X, Lim K, Avin KG
Journal of Cachexia, Sarcopenia and Muscle 2023
Circulating Activin A, Kidney Fibrosis, and Adverse Events
Tsai MT, Ou SM, Lee KH, Lin CC, Li SY
Clinical journal of the American Society of Nephrology : CJASN 2023
Multiorgan locked-state model of chronic diseases and systems pharmacology opportunities
Ung CY, Correia C, Li H, Adams CM, Westendorf JJ, Zhu S
Drug Discovery Today 2023
Kidneys control inter-organ homeostasis
V Puelles, T Huber
Nature Reviews Nephrology 2022
Muscle Wasting in Chronic Kidney Disease: Mechanism and Clinical Implications—A Narrative Review
Cheng TC, Huang SH, Kao CL, Hsu PC
International journal of molecular sciences 2022
Mechanisms of Post-critical Illness Cardiovascular Disease.
Owen A, Patel JM, Parekh D, Bangash MN
Frontiers in Cardiovascular Medicine 2022
Integrating basic science with translational research: the 13th International Podocyte Conference 2021
Lausecker F, Koehler S, Fresquet M, Naylor R, Tian P, Wanner N, Braun F, Butt L, Huber TB, Lennon R
Kidney International 2022
The impact of senescence on muscle wasting in chronic kidney disease
Huang Y, Wang B, Hassounah F, Price SR, Klein J, Mohamed TM, Wang Y, Park J, Cai H, Zhang X, Wang XH
Journal of Cachexia, Sarcopenia and Muscle 2022
Intensive Care Unit-Acquired Weakness in Patients With Acute Kidney Injury: A Contemporary Review.
Teixeira JP, Mayer KP, Griffin BR, George N, Jenkins N, Pal CA, González-Seguel F, Neyra JA
American journal of kidney diseases : the official journal of the National Kidney Foundation 2022
Myostatin/Activin-A Signaling in the Vessel Wall and Vascular Calcification
P Esposito, D Verzola, D Picciotto, L Cipriani, F Viazzi, G Garibotto
Cells 2021

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 2 news outlets
Posted by 49 X users
41 readers on Mendeley
See more details